HOMER3 Human

Homer Homolog-3 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Biological Functions

Scaffolding and Signaling: HOMER3 clusters postsynaptic density proteins, linking glutamate receptors (e.g., GRM1/5) to intracellular calcium channels (ITPR1/RYR1) to regulate calcium signaling . This coupling modulates synaptic plasticity and neuronal excitability .

Gene Regulation: In triple-negative breast cancer (TNBC), HOMER3 facilitates epidermal growth factor (EGF)-induced β-catenin tyrosine phosphorylation by scaffolding c-Src and β-catenin, promoting nuclear translocation and oncogenic signaling .

Mitochondrial Regulation: In non-small cell lung cancer (NSCLC), HOMER3 upregulates GABPB1 to enhance mitochondrial biogenesis and metastasis .

Cancer

  • TNBC: Overexpression correlates with metastasis and poor survival .

  • NSCLC: High HOMER3 levels predict reduced survival; knockdown suppresses proliferation and metastasis in vitro/in vivo .

Neurological Disorders

  • Autoimmune Cerebellar Ataxia: Anti-HOMER3 antibodies are linked to cerebellar atrophy, encephalopathy, and REM sleep behavior disorder. Clinical features include unsteady gait, slurred speech, and nystagmus .

  • Mechanism: Autoantibodies disrupt HOMER3-mediated coupling of GRM1 and ITPR1, impairing Purkinje cell calcium homeostasis .

Research Applications

  • Disease Modeling: Used to study synaptic dysfunction in neurological disorders and oncogenic signaling in cancers .

  • Therapeutic Targeting: Preclinical studies highlight HOMER3 as a vulnerability in TNBC and NSCLC .

Expression and Localization

  • Brain: Enriched in cerebellar Purkinje cells (cytoplasmic expression) .

  • Peripheral Tissues: Detected in thymus, lung, and cancer cells .

Key Research Findings

StudyKey InsightCitation
TNBC MetastasisHOMER3 scaffolds c-Src/β-catenin to drive EGF-induced metastasis
NSCLC Mitochondrial DysfunctionHOMER3 knockdown disrupts mitochondrial biogenesis via GABPB1 suppression
Autoimmune AtaxiaAnti-HOMER3 antibodies associate with cerebellar atrophy and poor immunotherapy response

Product Specs

Introduction
HOMER3, a member of the HOMER family of postsynaptic density scaffolding proteins, shares a conserved domain structure with its counterparts. This structure includes an N-terminal Enabled/vasodilator-stimulated phosphoprotein homology 1 (EVH1) domain, facilitating protein-protein interactions, along with two leucine zipper motifs and a C-terminal coiled-coil domain, both contributing to self-oligomerization.
Description
Recombinant human HOMER3, expressed in E. coli, is a single polypeptide chain encompassing 386 amino acids (residues 1-361) with a molecular weight of 42.5 kDa. The protein is appended with a 24 amino acid His-tag at the N-terminus and purified using proprietary chromatographic methods.
Physical Appearance
A clear, colorless solution, sterilized by filtration.
Formulation
The provided HOMER3 solution (1 mg/mL) is formulated in a buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM DTT, and 30% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freezing at -20°C is recommended. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freeze-thaw cycles should be avoided.
Purity
The purity of the protein is determined to be greater than 90% by SDS-PAGE analysis.
Synonyms
Homer homolog 3 (Drosophila)1 2 , HOMER-31 2 , homer protein homolog 32 , Homer neuronal immediate early gene 32, Homer-33, VESL32.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMMSTAR EQPIFSTRAH VFQIDPATKR NWIPAGKHAL TVSYFYDATR NVYRIISIGG AKAIINSTVT PNMTFTKTSQ KFGQWADSRA NTVYGLGFAS EQHLTQFAEK FQEVKEAARL AREKSQDGGE LTSPALGLAS HQVPPSPLVS ANGPGEEKLF RSQSADAPGP TERERLKKML SEGSVGEVQW EAEFFALQDS NNKLAGALRE ANAAAAQWRQ QLEAQRAEAE RLRQRVAELE AQAASEVTPT GEKEGLGQGQ SLEQLEALVQ TKDQEIQTLK SQTGGPREAL EAAEREETQQ KVQDLETRNA ELEHQLRAME RSLEEARAER ERARAEVGRA AQLLDVSLFE LSELREGLAR LAEAAP

Q&A

What is Homer-3 in human neurology and what is its significance in research?

Homer-3 is a postsynaptic scaffolding protein primarily expressed in the dendritic spines of Purkinje cells in the cerebellum. It plays a critical role in cross-linking metabotropic glutamate receptor 1 (mGluR1) to intracellular calcium channels (ITPR1), thereby regulating calcium equilibrium in Purkinje cells in response to mGluR1 activation . In neuroscience research, Homer-3 is significant as autoantibodies against this protein are associated with autoimmune cerebellar ataxia (ACA) and other neurological manifestations, making it an important biomarker for certain autoimmune neurological disorders .

How are Homer-3 antibodies detected in clinical research settings?

Detection of Homer-3 antibodies in clinical research typically employs both cell-based and tissue-based assays. In tissue-based assays, patient serum or CSF is applied to fixed monkey cerebellum sections, where Homer-3 antibodies will react with the cytoplasm and dendrites of Purkinje cells while sparing the nucleus . This characteristic staining pattern is then confirmed using cell-based assays that express the Homer-3 antigen . These complementary approaches ensure accurate identification of Homer-3 antibodies in research and diagnostic contexts.

What is the clinical spectrum of Homer-3 antibody-associated neurological disorders?

Homer-3 antibody-associated disorders present with a spectrum of neurological manifestations. The primary presentation is cerebellar ataxia, characterized by dizziness, unsteady gait, limb ataxia, slurred speech, and nystagmus . Beyond cerebellar symptoms, patients may exhibit:

Clinical ManifestationSpecific FeaturesFrequency in Studies
Cerebellar AtaxiaDizziness, unsteady gait, limb ataxia, slurred speech, nystagmus6/6 patients
EncephalopathyPsychosis, seizures, confusion, cognitive impairment2/6 patients
MyeloradiculopathyLimb weakness, hyporeflexia, denervation on EMG2/6 patients
REM Sleep Behavior Disorder-2/6 patients
Autonomic Dysfunction-2/6 patients

Brain MRI findings are variable, ranging from normal appearance to cerebellar atrophy, cerebellum and pons atrophy with the hot cross bun sign, or bilateral cerebral abnormalities .

How does Homer-3 antibody testing compare with other diagnostic approaches for cerebellar ataxia?

Homer-3 antibody testing represents one component of a comprehensive diagnostic approach for cerebellar ataxia. While testing for this antibody has high specificity, with negative results in healthy controls and patients with other types of cerebellar ataxia , its relative rarity makes unbiased screening clinically impractical. Diagnostic evaluation should include clinical assessment (onset characteristics, associated symptoms), neuroimaging (MRI patterns), CSF analysis (inflammatory markers), and testing for other autoimmune, paraneoplastic, metabolic, and genetic causes of ataxia . Key distinguishing features suggesting Homer-3 antibody-associated ataxia include acute/subacute onset, cerebral and nerve root involvement, lack of dysautonomia, and inflammatory changes in CSF .

What are the treatment approaches and outcomes for Homer-3 antibody-associated disorders?

Treatment of Homer-3 antibody-associated disorders centers on immunotherapy. In clinical research, patients have received combinations of intravenous immunoglobulin (IVIg), corticosteroids, plasma exchange, and mycophenolate mofetil . Treatment responses are variable, with most patients (4 out of 6 in one study) showing partial improvement or stabilization of symptoms, while some continue to deteriorate despite immunotherapy .

Treatment OutcomeProportion of PatientsNotes
Partial improvement4/6Regarding ataxia, weakness, and encephalopathy
Stabilization1/6No further progression but no improvement
Continued deterioration1/6Despite repeated immunotherapy
Relapse2/4 improved patientsDuring corticosteroid weaning or after IVIg discontinuation
Residual disability4/6Modified Rankin Scale score ≥3 at follow-up

Long-term outcomes often include significant residual disability, with SARA (Scale for the Assessment and Rating of Ataxia) scores ranging from 12 to 29 at the last follow-up .

How do Homer-3 antibody-associated disorders mimic multiple system atrophy with cerebellar features (MSA-C)?

FeatureMSA-CHomer-3 Antibody DisordersDistinguishing Factors
Clinical OnsetInsidiousOften subacute/acuteTempo of symptom development
Brain/Nerve InvolvementPrimarily cerebellarMay have cerebral and nerve root involvementDistribution of neurological deficits
CSF ProfileGenerally normalMay show inflammatory changesPresence of leukocytosis, protein elevation, oligoclonal bands
Response to TreatmentPoor, progressiveMay respond to immunotherapyTherapeutic trial may be diagnostic
DysautonomiaProminentMay be absent or less prominentSeverity of autonomic symptoms

Distinguishing between these conditions is crucial as MSA-C is a progressively deteriorating neurodegenerative disease without effective treatment, whereas Homer-3 antibody-associated cerebellar syndrome may respond to immunotherapy .

What is the proposed pathophysiological mechanism of Homer-3 antibodies in neurological disorders?

The exact pathophysiological mechanism of Homer-3 antibodies remains incompletely understood. As Homer-3 is an intracellular protein, the antibodies themselves are likely not directly pathogenic, similar to other antibodies targeting intracellular components like anti-Yo and anti-Hu, which showed no pathogenicity in animal experiments . Instead, the neurological damage may be mediated by T lymphocytes .

Homer-3's role in cross-linking mGluR1 to ITPR1 and regulating calcium equilibrium in Purkinje cells suggests that disruption of this pathway could contribute to cerebellar dysfunction . The broader neurological manifestations (encephalopathy, myeloradiculopathy, RBD, dysautonomia) might reflect Homer-3's expression in other neural tissues or epitope spread to additional neuronal antigens.

What is HOMER3 software and how is it used in brain research?

HOMER3 is an open-source MATLAB application designed for analyzing functional Near-Infrared Spectroscopy (fNIRS) data to obtain estimates and maps of brain activation . It represents an evolution of the well-established HOMER2 software, which itself developed from the Photon Migration Imaging Toolbox dating back to the early 1990s .

Developed and maintained by the Boston University Neurophotonics Center, HOMER3 allows researchers to process fNIRS data, which measures hemodynamic responses in the brain during cognitive tasks or stimuli, similar to fMRI but with different temporal and spatial characteristics. The software provides tools for preprocessing, analysis, and visualization of brain activation patterns derived from optical measurements .

What are the technical requirements and installation procedures for HOMER3?

Installation ComponentMethodNotes
Main HOMER3 PackageDownload latest releaseNot via "Download .zip" or cloning
Submodule LibrariesManual download from respective repositoriesMust be placed in the \Homer3 folder
MATLAB CompatibilityWorks with MATLAB 2017b and othersSpecific version compatibility not fully detailed
SupportHomer3 & AtlasViewer community forum on openfnirs.orgFor usage questions
Bug ReportsGitHub issuesFor reporting bugs or suggesting features
DocumentationGitHub wikiWork in progress

The software has been used with various MATLAB versions, including MATLAB 2017b with MATLAB Runtime V9.3 .

What data analysis capabilities does HOMER3 offer for fNIRS research?

HOMER3 provides a comprehensive suite of analysis tools for fNIRS data. While the search results don't detail all specific capabilities, HOMER3 enables researchers to analyze fNIRS data to:

  • Process raw optical data to obtain changes in hemoglobin concentration (HbO, HbR, and HbT)

  • Compare brain activation between different experimental conditions

  • Conduct statistical analyses of brain activation data, including p-value calculations

  • Visualize brain activation patterns and statistical results

  • Implement processing streams for data analysis, allowing for customized analysis workflows

The software continues the analytical approaches detailed in previous publications on HomER, which include time-series analysis methods for near-infrared spectroscopy of the brain .

How can researchers handle multiple experimental conditions in HOMER3?

HOMER3 allows researchers to analyze and contrast brain activation across multiple experimental conditions. Based on the search results, researchers can set up their data to include multiple conditions (e.g., "0-back, 1-back, 2-back" in a visual n-back task) with multiple trials per condition .

Experimental Design ElementImplementation in HOMER3Example
Multiple ConditionsConfigurable in processing stream0-back, 1-back, 2-back conditions
Multiple TrialsMultiple instances per condition2 trials per condition
Hemoglobin SpeciesSeparate analysis for eachHbO, HbR, and HbT contrasts
Statistical ComparisonBetween-condition contrastsComparing 2-back vs. 0-back
Results VisualizationP-value display tool(Note: Some users report issues with this feature)

The software appears to support creating contrasts between these conditions to examine differences in hemoglobin species activity . Researchers need to properly set up their files and processing stream to enable these comparisons. The interface includes tools for displaying statistical results, such as p-values, although some users have reported difficulties with this functionality .

What common challenges do researchers face when using HOMER3 and how can they be addressed?

Based on the limited search results, some challenges researchers face when using HOMER3 include:

  • Difficulty in interpreting output and locating results of analyses

  • Issues with the "display p-value" functionality

  • Challenges in setting up proper file structures and processing streams

  • Potential difficulties in obtaining meaningful results even when files and processing streams appear to be correctly configured

These challenges may be particularly pronounced for researchers with limited coding experience . The search results suggest that support for users is available via the Homer3 & AtlasViewer community forum hosted on openfnirs.org . Additionally, users can report bugs or suggest features by creating issues on the GitHub repository .

How should researchers cite HOMER3 in their publications?

Researchers using HOMER3 in their studies should cite the original publication as specified by the developers :

Huppert, T., Diamond, S., Franceschini, M., Boas, D. (2009). HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain. Applied optics 48(10). https://dx.doi.org/10.1364/ao.48.00d280

While HOMER3 is BSD licensed, the developers specifically request citation of this publication when the software is used in research . Proper attribution ensures recognition of the intellectual contribution of the developers and helps track the software's impact in the scientific community.

What steps should researchers take to ensure reliable and reproducible results when using HOMER3?

Based on best practices in neuroimaging and the available search results, researchers should consider the following steps to ensure reliable and reproducible results when using HOMER3:

StepImplementationPurpose
Experimental DesignClear conditions with sufficient trialsEnsure adequate signal-to-noise ratio
Data OrganizationStructure according to HOMER3 requirementsEnable proper software processing
PreprocessingImplement appropriate noise reduction stepsMinimize artifacts in fNIRS data
Processing StreamDocument all analysis parametersEnable replication by others
Analysis VerificationCheck results against expected patternsConfirm correct functioning of analysis tools
DocumentationShare processing streams in publicationsEnhance reproducibility
ContributionFollow development guidelines for improvementsHelp advance the software

When publishing results, researchers should cite the original HOMER publication and consider sharing their processing streams and analysis parameters to enhance reproducibility for other researchers.

What are the current limitations of HOMER3 and how might they be addressed in future research?

While the search results don't explicitly detail HOMER3's limitations, several challenges can be inferred:

  • Difficulty in interpreting outputs for users with limited coding experience

  • Issues with specific functionalities like the p-value display tool

  • Incomplete documentation, described as "a work in progress"

  • Dependency on MATLAB, which may limit accessibility for some researchers

Future research and development efforts might address these limitations through:

  • Enhanced documentation with step-by-step tutorials for various analysis scenarios

  • Improved user interface elements to facilitate result interpretation

  • Expanded statistical tools with more intuitive visualization options

  • Development of standalone versions that don't require a MATLAB license

  • Integration capabilities with other neuroimaging modalities for multimodal analysis

The open-source nature of HOMER3 and the developers' invitation for community contributions provide a framework for addressing these limitations through collaborative efforts from the fNIRS research community.

Product Science Overview

Structure and Function

HOMER3 shares a similar domain structure with other members of the Homer family. It consists of:

  • An N-terminal Enabled/vasodilator-stimulated phosphoprotein homology 1 (EVH1) domain, which mediates protein-protein interactions.
  • A carboxy-terminal coiled-coil domain and two leucine zipper motifs, which are involved in self-oligomerization .

These structural features enable HOMER3 to interact with various proteins and contribute to the formation and maintenance of synaptic structures. HOMER3 is particularly important in the postsynaptic density (PSD) of neurons, where it helps regulate the size and strength of synapses .

Role in Synaptic Plasticity

Synaptic plasticity is the ability of synapses to strengthen or weaken over time in response to changes in activity. This process is essential for learning, memory, and overall brain function. HOMER3, along with other Homer proteins, plays a key role in modulating synaptic plasticity by:

  • Regulating calcium signaling: HOMER3 interacts with metabotropic glutamate receptors (mGluRs) and inositol trisphosphate receptors (IP3Rs), which are involved in calcium signaling pathways .
  • Maintaining synaptic integrity: By interacting with various synaptic proteins, HOMER3 helps maintain the structural integrity of synapses and ensures proper synaptic function .
Expression and Localization

HOMER3 is expressed in various tissues, including the brain, heart, kidney, muscle, ovary, and testicles . In the brain, it is predominantly localized in the postsynaptic density of neurons, where it plays a critical role in synaptic function and plasticity .

Recombinant HOMER3

Recombinant HOMER3 is a form of the protein that is produced using recombinant DNA technology. This involves inserting the gene encoding HOMER3 into a host organism, such as E. coli, which then produces the protein. Recombinant HOMER3 is often used in research to study the protein’s structure, function, and interactions with other proteins .

The recombinant human HOMER3 protein typically includes a His-tag at the N-terminus to facilitate purification and detection. It is expressed in E. coli and purified using conventional chromatography techniques .

Applications in Research

Recombinant HOMER3 is used in various research applications, including:

  • Studying synaptic plasticity: Researchers use recombinant HOMER3 to investigate its role in synaptic plasticity and its interactions with other synaptic proteins.
  • Understanding neurological disorders: Dysregulation of Homer proteins, including HOMER3, has been implicated in various neurological disorders, such as autism, anxiety, and addiction . Studying recombinant HOMER3 can provide insights into the mechanisms underlying these conditions.
  • Drug development: By understanding the role of HOMER3 in synaptic function, researchers can develop targeted therapies for neurological disorders that involve dysregulation of synaptic plasticity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.